1.5 Million U.S. Adults Have Vision-Affecting Glaucoma

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 18, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, Oct. 18, 2024 -- An estimated 2.56 percent of U.S. adults ages 40 years and older have glaucoma, according to a study published online Oct. 17 in JAMA Ophthalmology.

Joshua R. Ehrlich, M.D., from University of Michigan, Ann Arbor, and colleagues used the Centers for Disease Control and Prevention Vision and Eye Health Surveillance System to estimate glaucoma prevalence among U.S. states and counties in 2022.

The researchers found that an estimated 4.22 million people were living with glaucoma in the United States in 2022. The prevalence was 1.62 percent for adults overall and 2.56 percent for those ages 40 years and older. Vision-affecting glaucoma impacted an estimated 1.49 million people (0.57 percent of adults overall and 0.91 percent among people ages 40 years and older). Geographic prevalence varied from 1.11 percent of adults in Utah to 1.95 percent in Mississippi. Prevalence was higher among Black adults versus White (3.15 and 1.42 percent, respectively). For Hispanic adults, the prevalence was 1.56 percent.

“These estimates may help provide information for the development and prioritization of public health strategies and interventions, the monitoring of epidemiologic trends, and evaluation of programs tailored for communities and populations at highest risk of glaucoma,” the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-19 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords